<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:48:41Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3675082" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3675082</identifier><datestamp>2013-06-12</datestamp><setSpec>plosone</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3675082</article-id>
      <article-id pub-id-type="pmcid">PMC3675082</article-id>
      <article-id pub-id-type="pmc-uid">3675082</article-id>
      <article-id pub-id-type="pmid">23762398</article-id>
      <article-id pub-id-type="pmid">23762398</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-13-04084</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0065586</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Biochemistry</subject>
            <subj-group>
              <subject>Proteins</subject>
              <subj-group>
                <subject>Protein Interactions</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Human Genetics</subject>
              <subj-group>
                <subject>Chromosomal Disorders</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Molecular Cell Biology</subject>
            <subj-group>
              <subject>Signal Transduction</subject>
              <subj-group>
                <subject>Signaling Cascades</subject>
                <subj-group>
                  <subject>Akt Signaling Cascade</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Clinical Genetics</subject>
            <subj-group>
              <subject>Chromosomal Disorders</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Interaction between NBS1 and the mTOR/Rictor/SIN1 Complex through Specific Domains</article-title>
        <alt-title alt-title-type="running-head">NBS Interacts with the mTOR/Rictor/SIN1 Complex</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Wang</surname>
            <given-names>Jian-Qiu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Chen</surname>
            <given-names>Jian-Hong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yen-Chung</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="fn1">
<sup>Â¤</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Mei-Yu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hsieh</surname>
            <given-names>Chia-Ying</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teng</surname>
            <given-names>Shu-Chun</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Kou-Juey</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<label>1</label>
<addr-line>Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan</addr-line>
</aff>
      <aff id="aff2">
<label>2</label>
<addr-line>Institute of Aging Research, Department of Basic Medical Science, School of Medicine, Hangzhou Normal University, Hangzhou, China</addr-line>
</aff>
      <aff id="aff3">
<label>3</label>
<addr-line>Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan</addr-line>
</aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Ouchi</surname>
            <given-names>Toru</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
<addr-line>University of Chicago, United States of America</addr-line>
</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>kjwu2@ym.edu.tw</email></corresp>
        <fn fn-type="COI-statement">
          <p><bold>Competing Interests: </bold>The authors declared that there are no competing interests.</p>
        </fn>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: KJW. Performed the experiments: JQW JHC YCC CYH. Analyzed the data: KJW SCT. Contributed reagents/materials/analysis tools: MYC. Wrote the paper: KJW SCT. Provided the mTOR and Rictor plasmids: MYC.</p>
        </fn>
        <fn id="fn1" fn-type="current-aff">
          <label>Â¤</label>
          <p>Current address: Taiwan Advance Biopharm, Inc., Xizhi city, New Taipei City, Taiwan</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>6</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <issue>6</issue>
      <elocation-id>e65586</elocation-id>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>1</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>4</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2013 Wang et al</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Wang et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Nijmegen breakage syndrome (NBS) is a chromosomal-instability syndrome. The NBS gene product, NBS1 (p95 or nibrin), is a part of the Mre11-Rad50-NBS1 complex. SIN1 is a component of the mTOR/Rictor/SIN1 complex mediating the activation of Akt. Here we show that NBS1 interacted with mTOR, Rictor, and SIN1. The specific domains of mTOR, Rictor, or SIN1 interacted with the internal domain (a.a. 221-402) of NBS1. Sucrose density gradient showed that NBS1 was located in the same fractions as the mTOR/Rictor/SIN1 complex. Knockdown of NBS1 decreased the levels of phosphorylated Akt and its downstream targets. Ionizing radiation (IR) increased the NBS1 levels and activated Akt activity. These results demonstrate that NBS1 interacts with the mTOR/Rictor/SIN1 complex through the a.a. 221â402 domain and contributes to the activation of Akt activity.</p>
      </abstract>
      <funding-group>
        <funding-statement>This work was supported in part to KJW by National Research Program for Genomic Medicine (NRPGM-DOH-99-TD-G-111-024, NSC100-3112-B-010-003),National Science Council Frontier grant (NSC101-2321-B-010-002), National Research Program for Biopharmaceuticals (NSC101-2325-B-010-004), a grant from Ministry of Education, Aim for the Top University Plan (101AC-T505, 102AC-TC13), center of excellence for cancer research at Taipei Veterans General Hospital (DOH101-TD-C-111-007), Taichung Veterans General Hospital (TCVGH-YM1000301, TCVGH-YM1010301), and National Health Research Institutes (NHRI-EX101-9931BI, NHRI-EX102-10230SI); and to MYC by National Science Council (NSC98-2320-B-010-023) and a grant from Ministry of Education, Aim for the Top University Plan (102AC-TC15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="8"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Nijmegen breakage syndrome (NBS) is a chromosomal-instability syndrome with the manifestation of cancer predisposition, radiosensitivity, microcephaly, and growth retardation <xref rid="pone.0065586-Czorna1" ref-type="bibr">[1]</xref>â<xref rid="pone.0065586-DAmours1" ref-type="bibr">[3]</xref>. The NBS gene product, NBS1 (p95 or nibrin), is a part of the Mre11-Rad50-NBS1 complex that is essential for DNA double strand break repair <xref rid="pone.0065586-Czorna1" ref-type="bibr">[1]</xref>, <xref rid="pone.0065586-Antoccia1" ref-type="bibr">[2]</xref>. NBS1 carries out its checkpoint functions through the phosphorylation by ataxia-telangiectasia mutated (ATM) protein after ionizing radiation <xref rid="pone.0065586-LimD1" ref-type="bibr">[4]</xref>â<xref rid="pone.0065586-Wu1" ref-type="bibr">[6]</xref>. We previously demonstrated that c-MYC, an oncoprotein, directly activates the expression of NBS1 <xref rid="pone.0065586-Chiang1" ref-type="bibr">[7]</xref>. The function of NBS1 related to proliferation is demonstrated by the phenotypes of diminished expansion of the inner cell mass of mutant blastocysts (Nbs1 null) and cellular proliferation defects in Nbs1<bold><sup>m/m</sup></bold> mouse embryonic fibroblasts <xref rid="pone.0065586-Zhu1" ref-type="bibr">[8]</xref>â<xref rid="pone.0065586-Kang1" ref-type="bibr">[10]</xref>. Overexpression of NBS1 induces transformation activity through interacting with the p110 subunits of phosphoinositide 3-kinase (PI 3-kinase) to activate PI 3-kinase activity <xref rid="pone.0065586-Chen1" ref-type="bibr">[11]</xref>, <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>, indicating that NBS1 overexpression is an oncogenic event. In head and neck squamous cell carcinoma patients, increased NBS1 expression is a prognostic factor of aggressive head and neck cancer <xref rid="pone.0065586-Yang1" ref-type="bibr">[13]</xref>. All these results indicate that NBS1 overexpression may play an important role in tumorigenesis.</p>
      <p>Akt is a well-known downstream target of PI 3-kinase <xref rid="pone.0065586-Cantley1" ref-type="bibr">[14]</xref>, <xref rid="pone.0065586-Vivanco1" ref-type="bibr">[15]</xref>. Akt is activated through phosphorylation at Thr-308 by phosphoinositide-dependent protein kinase 1 followed by phosphorylation at Ser-473 by the mTOR/Rictor (mTORC2) complex to achieve full activation <xref rid="pone.0065586-Bellacosa1" ref-type="bibr">[16]</xref>, <xref rid="pone.0065586-Sarbassov1" ref-type="bibr">[17]</xref>. Activated Akt then regulates a wide range of target proteins that control cell proliferation (e.g. GSK-3Î², Foxo1/3a), survival (e.g. BAD), and cell growth (e.g. mTOR) <xref rid="pone.0065586-Vivanco1" ref-type="bibr">[15]</xref>. Akt regulates critical processes of tumorigenesis and plays an important role in oncogenesis <xref rid="pone.0065586-Bellacosa1" ref-type="bibr">[16]</xref>. Altered expression or mutation of many components of the PI3K/Akt pathway has been implicated in human cancer <xref rid="pone.0065586-Vivanco1" ref-type="bibr">[15]</xref>, <xref rid="pone.0065586-Testa1" ref-type="bibr">[18]</xref>. Recently, a new member of the mTORC2 complex, SIN1, was identified <xref rid="pone.0065586-Jacinto1" ref-type="bibr">[19]</xref>â<xref rid="pone.0065586-Frias1" ref-type="bibr">[21]</xref>. SIN1 is critical to maintain the mTORC2 complex and regulate Akt kinase activity and substrate specificity <xref rid="pone.0065586-Jacinto1" ref-type="bibr">[19]</xref>â<xref rid="pone.0065586-Frias1" ref-type="bibr">[21]</xref>. Other example such as TSC1-TSC2 complex was shown to associate with the mTORC2 complex and activate Akt kianse activity (Akt Ser-473 phosphorylation) <xref rid="pone.0065586-Huang1" ref-type="bibr">[22]</xref>. However, it remains to be explored whether other protein could participate in the mTORC2 complex to induce Akt kinase activity.</p>
      <p>In this report, we demonstrate that NBS1 interacts with the mTOR/Rictor/SIN1 complex using a specific domain (a.a. 221â402). The domain in mTOR, Rictor, or SIN1 that interacts with NBS1 is also mapped. Knockdown of NBS1 decreases Akt kinase activity. IR increased the levels of NBS1 and phosphorylated Akt. These results indicate that NBS1 is a critical component of the mTOR/Rictor/SIN1 complex to activate Akt kinase.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <sec id="s2a">
        <title>Interaction between NBS1 and the Components of the mTOR/Rictor/SIN1 Complex</title>
        <p>We previously demonstrated that NBS1 interacted with the p110Î± subunit of the PI 3-kinase to induce PI 3-kinase/Akt activity <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>. However, it is possible that NBS1 may also interact with Akt to induce Akt activity. To test whether there is interaction between NBS1 and the mTOR/Rictor/SIN1 complex that is responsible for the activation of Akt activity, co-immunoprecipitation assays were performed between NBS1 and each component of the mTOR/Rictor/SIN1 complex. The results showed that the anti-NBS1 antibody pulled down mTOR in 293T cells overexpressing both NBS1 and mTOR (<xref ref-type="fig" rid="pone-0065586-g001">Fig. 1A</xref>). In addition, the anti-mTOR antibody also pulled down NBS1 (<xref ref-type="fig" rid="pone-0065586-g001">Fig. 1B</xref>), demonstrating their interaction when both proteins were overexpressed in 293T cells. Similar assays were performed to test the interaction between NBS1 and Rictor and the results showed that NBS1 interacted with Rictor in 293T cells overexpressing both proteins (<xref ref-type="fig" rid="pone-0065586-g001">Fig. 1CâD</xref>). Finally, similar assays were performed to test the interaction between NBS1 and SIN1Î², which also showed the interaction between these two proteins (<xref ref-type="fig" rid="pone-0065586-g001">Fig. 1EâF</xref>). All the results demonstrated that NBS1 interacted with the mTOR/Rictor/SIN1 complex.</p>
        <fig id="pone-0065586-g001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Interaction between NBS1 and the mTOR/Rictor/SIN1 complex.</title>
            <p>
<bold>A &amp; B.</bold> Co-immunoprecipitation assays showed the interaction between NBS1 and mTOR in 293T cells overexpressing both proteins. <bold>C &amp; D.</bold> Co-immunoprecipitation assays showed the interaction between NBS1 and Rictor in 293T cells overexpressing both proteins. <bold>E &amp; F.</bold> Co-immunoprecipitation assays showed the interaction between NBS1 and SIN1Î² in 293T cells overexpressing both proteins.</p>
          </caption>
          <graphic xlink:href="pone.0065586.g001"/>
        </fig>
      </sec>
      <sec id="s2b">
        <title>Mapping of Domain in mTOR or Rictor Interacting with NBS1</title>
        <p>In order to map the domain in mTOR or Rictor that interacts with NBS1, different truncation mutants of mTOR or Rictor were generated. Different truncation mutants of mTOR (mTOR1-651, mTOR640-1418, and mTOR1401-2549) were co-expressed with NBS1 in 293T cells followed by co-immunoprecipitation. The results showed that only mTOR1-651 interacted with NBS1 (<xref ref-type="fig" rid="pone-0065586-g002">Fig. 2AâB</xref>). The full length and different truncation mutants of Rictor (Rictor1-1708, Rictor1-789, and Rictor664-1708) were co-expressed with NBS1 in 293T cells followed by co-immunoprecipitation. Co-immunoprecipitation experiments showed that the domain 1-789 a.a. of Rictor interacted with NBS1 (<xref ref-type="fig" rid="pone-0065586-g002">Fig. 2CâD</xref>). These results indicated that the N-terminal domains (1-651 a.a. domain of mTOR and 1-789 a.a. domain of Rictor) of both proteins interacted with NBS1.</p>
        <fig id="pone-0065586-g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Mapping of the domain in mTOR or Rictor interacting with NBS1.</title>
            <p>
<bold>A &amp; B.</bold> Co-immunoprecipitation assays showed the interaction between the N-terminal domain of mTOR and NBS1. Whole cell extracts were shown in A. <bold>C &amp; D.</bold> Co-immunoprecipitation assays showed the interaction between the N-terminal domain of Rictor and NBS1. Whole cell extracts were shown in C.</p>
          </caption>
          <graphic xlink:href="pone.0065586.g002"/>
        </fig>
      </sec>
      <sec id="s2c">
        <title>Mapping of the NBS1 Domain Interacting with mTOR or Rictor</title>
        <p>In order to map the domain in NBS1 that interacts with mTOR or Rictor, different truncation mutants of NBS1 (C-terminal truncation mutant NBS1-653 and N-terminal truncation mutant NBSp70) were co-expressed with mTOR or Rictor followed by co-immunoprecipitation <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>. The result showed that both the mutants interacted with mTOR and Rictor (<xref ref-type="fig" rid="pone-0065586-g003">Fig. 3A, C</xref>). Further fine mapping of the domain using two different NBS1 truncation mutants (NBS221-402 and NBS402-653) together with mTOR or Rictor showed that only NBS221-402 interacted with mTOR and Rictor (<xref ref-type="fig" rid="pone-0065586-g003">Fig. 3B, D</xref>). All the results indicated that the internal domain (a.a. 221-402) of NBS1 interacted with both mTOR and Rictor.</p>
        <fig id="pone-0065586-g003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Mapping of the domain in NBS1 interacting with mTOR or Rictor.</title>
            <p>
<bold>A &amp; B.</bold> Co-immunoprecipitation assays showed the interaction of the internal domain (a.a. 221-402) of NBS1 with mTOR. <bold>C &amp; D.</bold> Co-immunoprecipitation assays showed the interaction of the internal domain of NBS1 with Rictor.</p>
          </caption>
          <graphic xlink:href="pone.0065586.g003"/>
        </fig>
      </sec>
      <sec id="s2d">
        <title>Mapping of the Interacting Domain between NBS1 and SIN1Î²</title>
        <p>To map the domain in SIN1Î² that interacts with NBS1, different SIN1Î² truncation mutants (SIN1Î²1-267, SIN1Î²266-487, SIN1Î²336-487) were co-expressed with NBS1 in 293T cells followed by co-immunoprecipitation. The result showed that only SIN1Î²1-267 interacted with NBS1 (<xref ref-type="fig" rid="pone-0065586-g004">Fig. 4A</xref>). To map the domain in NBS1 interacting with SIN1Î², different NBS1 truncation mutants as mentioned above were co-expressed with SIN1Î² in 293T cells followed by co-immunoprecipitation. The result showed that the domain in NBS1 interacting with SIN1Î² was also mapped to the a.a. 221-402 domain of NBS1 (<xref ref-type="fig" rid="pone-0065586-g004">Fig. 4B</xref>).</p>
        <fig id="pone-0065586-g004" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Mapping of the domain of SIN1Î² or NBS1 interacting with each other.</title>
            <p>
<bold>A.</bold> Co-immunoprecipitation assays showed the interaction of the N-terminal domain (a.a. 1-267) of SIN1Î² with NBS1. <bold>B.</bold> Co-immunoprecipitation assays showed the interaction of the internal domain (a.a. 221-402) of NBS1 with SIN1Î².</p>
          </caption>
          <graphic xlink:href="pone.0065586.g004"/>
        </fig>
      </sec>
      <sec id="s2e">
        <title>
<italic>In vivo</italic> Interaction between NBS1 and the mTOR/Rictor/SIN1 Complex</title>
        <p>In order to test whether NBS1 indeed interacts with the mTOR/Rictor/SIN1 complex, co-immunoprecipitation assays using extracts from a lung cancer cell line H1299 were used. The result showed that the anti-NBS1 antibody pulled down mTOR, Rictor, and SIN1Î² (<xref ref-type="fig" rid="pone-0065586-g005">Fig. 5A, left panel</xref>), supporting their interaction <italic>in vivo</italic>. Co-immunoprecipitation experiment using the anti-Raptor antibody did not pull down the whole mTOR/Rictor/SIN1 complex or NBS1 (<xref ref-type="fig" rid="pone-0065586-g005">Fig. 5A, right panel</xref>), indicating that NBS1 did not interact with the mTOR/Raptor complex. Finally, a sucrose density gradient experiment using extracts from H1299 cells was performed to test whether these proteins were localized in the same fraction. The result showed that indeed NBS1, mTOR, Rictor, and SIN1Î² were localized in the same fraction (fraction 4 is the major fraction) (<xref ref-type="fig" rid="pone-0065586-g005">Fig. 5B</xref>). All the results indicated that NBS1 interacted with the mTOR/Rictor/SIN1 complex <italic>in</italic>
<italic>vivo</italic>.</p>
        <fig id="pone-0065586-g005" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Co-immunoprecipitation assays and sucrose density gradient analysis showed the interaction between NBS1 and the mTOR/Rictor/SIN1 complex <italic>in vivo</italic>.</title>
            <p>
<bold>A.</bold> Co-immunoprecipitation assays showed the <italic>in</italic>
<italic>vivo</italic> interaction of NBS1 with the mTOR/Rictor/SIN1 complex using extracts from H1299 cell line. <bold>B.</bold> Sucrose density gradient analysis showed the co-localization in the same fractions between NBS1 and the mTOR/Rictor/SIN1 complex.</p>
          </caption>
          <graphic xlink:href="pone.0065586.g005"/>
        </fig>
      </sec>
      <sec id="s2f">
        <title>Knockdown of NBS1 Decreased the Levels of Phosphorylated Akt and its Downstream Targets</title>
        <p>In order to test the correlation between NBS1 levels and its effect on the Akt activity, siRNA experiment to knockdown NBS1 was performed. The result showed that knockdown of NBS1 decreased the phosphorylated Akt levels (pAkt Ser-473) (<xref ref-type="fig" rid="pone-0065586-g006">Fig. 6</xref>), indicating that NBS1 contributed to the Akt activity. In addition, the phosphorylation levels of certain Akt downstream targets such as GSK-3Î² and Foxo1/3a were also decreased following NBS1 knockdown (<xref ref-type="fig" rid="pone-0065586-g006">Fig. 6A</xref>). These results supported the role of NBS1 in the activation of Akt activity.</p>
        <fig id="pone-0065586-g006" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.g006</object-id>
          <label>Figure 6</label>
          <caption>
            <title>siRNA mediated knockdown of NBS1 decreased the levels of phosphorylated Akt (pAkt Ser-473) and its downstream targets and IR increased the levels of NBS1 and phosphorylated Akt.</title>
            <p>
<bold>A.</bold> Western blot analysis showed that knockdown of NBS1 decreased the phosphorylated levels of Akt, GSK-3Î², and Foxo1/3a). <bold>B.</bold> Ionizing radiation of two different cell lines (H1299, OCEM-1) increased the levels of NBS1 and phosphorylated Akt. <bold>C.</bold> Knockdown of NBS1 in H1299 cells abolished the increase in NBS1 and phosphorylated Akt levels under IR.</p>
          </caption>
          <graphic xlink:href="pone.0065586.g006"/>
        </fig>
      </sec>
      <sec id="s2g">
        <title>Ionizing Radiation (IR) Increased the NBS1 Levels and Activated Akt</title>
        <p>Since IR was shown to activate Akt signaling <xref rid="pone.0065586-Contessa1" ref-type="bibr">[23]</xref>, <xref rid="pone.0065586-Suman1" ref-type="bibr">[24]</xref>, we tested the physiological relevance of NBS1 to activate Akt activity through IR. IR increased the levels of NBS1 and phosphorylated Akt (pAkt Ser-473) in two different cell lines (<xref ref-type="fig" rid="pone-0065586-g006">Fig. 6B</xref>). Knockdown of NBS1 in H1299 cells abolished the increase in the levels of NBS1 and phosphorylated Akt under IR treatment (<xref ref-type="fig" rid="pone-0065586-g006">Fig. 6C</xref>). These results supported the physiological role of NBS1 to activate Akt activity.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p>Overexpression of NBS1 was previously shown to induce transformation through the PI 3-kinase/Akt pathway <xref rid="pone.0065586-Chen1" ref-type="bibr">[11]</xref>â<xref rid="pone.0065586-Yang1" ref-type="bibr">[13]</xref>. However, in this report, we demonstrated that NBS1 overexpression could also interact with the mTOR/Rictor/SIN1 complex to activate Akt activity. This result is the further extension of the ability of NBS1 to interact with both the upstream PI3K and downstream Akt to regulate the activity of PI3K/Akt pathway. It is also supported by recent literatures demonstrating the dual function of NBS1 in the repair of DNA breaks and proliferation and the requirement of NBS1 in IGF-1 induced cellular proliferation <xref rid="pone.0065586-Saidi1" ref-type="bibr">[25]</xref>, <xref rid="pone.0065586-Hematulin1" ref-type="bibr">[26]</xref>. In addition, the ability of RNA regulon to promote Akt activity also goes through the upregulation of NBS1 levels <xref rid="pone.0065586-Culjkovic1" ref-type="bibr">[27]</xref>. Both results support the role of NBS1 in the activation of Akt activity.</p>
      <p>SIN1 was the critical molecule recently demonstrated to be important for the activation of Akt activity through interacting with the mTOR/Rictor complex <xref rid="pone.0065586-Jacinto1" ref-type="bibr">[19]</xref>â<xref rid="pone.0065586-Frias1" ref-type="bibr">[21]</xref>. Other molecules that could interact with the mTOR/Rictor complex were also recently identified including PRR5 and the TSC1/TSC2 complex <xref rid="pone.0065586-Huang1" ref-type="bibr">[22]</xref>, <xref rid="pone.0065586-Woo1" ref-type="bibr">[28]</xref>. The ability of NBS1 to interact with each component of the mTOR/Rictor/SIN1 complex showed that NBS1 may be another critical component of the mTOR/Rictor/SIN1 complex, which was supported by the result that knockdown of NBS1 decreased the phosphorylation levels of Akt and its downstream targets (<xref ref-type="fig" rid="pone-0065586-g006">Fig. 6A</xref>). In addition, knockdown of NBS1 abolished the increase in NBS1 and phosphorylated Akt levels under IR, supporting the physiological relevance of NBS1 in the activation of Akt activity (<xref ref-type="fig" rid="pone-0065586-g006">Fig. 6BâC</xref>). This result also points to the role of a DNA double strand break repair protein to activate Akt activity. It is interesting that NBS1 uses the same internal domain (a.a. 221-402) to interact with each component of the mTOR/Rictor/SIN1 complex. This domain contains the ATM-dependent phosphorylation sites (Ser278, Ser343, Ser397). In contrast, NBS1 uses the conserved C-terminal domain (a.a. 653-669) to interact with the subunits of PI3K to achieve its activation <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>. Further structural analysis of co-crystalized NBS1 and the mTOR/Rictor/SIN1 complex will delineate the molecular interactions between these molecules. Our previous results showed that increased NBS1 expression was constantly observed in different tumor samples <xref rid="pone.0065586-Chen1" ref-type="bibr">[11]</xref>, <xref rid="pone.0065586-Yang1" ref-type="bibr">[13]</xref>, <xref rid="pone.0065586-Yang3" ref-type="bibr">[29]</xref>, suggesting that increased NBS1 levels in tumor tissues may contribute significantly to the increased Akt activity observed in different tumor samples. Our discovery points to the unique role of NBS1 in the activation of the PI3K/Akt pathway using a newly identified internal domain (a.a 221-402) to interact with the mTOR/Rictor/SIN1 complex to achieve activation.</p>
    </sec>
    <sec sec-type="materials|methods" id="s4">
      <title>Materials and Methods</title>
      <sec id="s4a">
        <title>Cell Lines, Plasmids, Transfections, and Stable Clones</title>
        <p>The human embryonic kidney 293T and H1299 (a non-small cell lung cancer cell line) were previously described <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>, <xref rid="pone.0065586-Yang4" ref-type="bibr">[30]</xref>. The OCEM-1 cell line is a head and neck cancer line obtained from ATCC. The Flag-NBS1 full length and its truncation mutants were described <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>. The pSUPER-NBS1 and pSUPER-scrambled-si constructs were described <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>. The full length HA-mTOR expression vector was constructed by assembling fragments containing the nucleotides 1-4254 and 4201-7650 of the <italic>mTOR</italic> gene that were amplified from the human Marathon-Ready brain cDNA (Clontech) by PCR and subcloned into the yTA (Yeastern) vector. The sequences of primers used were <named-content content-type="gene">5â²-CAATTGGTCGACATGCTTGGAACCGGACCTGC-3â²</named-content> and <named-content content-type="gene">5â²-GCTAGCGCGCTAGCTGATGAGAGATTCTAGAATGG-3â²</named-content> for <italic>mTOR</italic> (1-4254), and <named-content content-type="gene">5â²-GAACTGGAGTTCCAGTTCCAGAAAGGC-3â²</named-content> and <named-content content-type="gene">5â²-CAATTGGCGCGCTTACCAGAAAGGGCACCAGC-3â²</named-content> for <italic>mTOR</italic> (4201-7650).</p>
        <p>The yTA-mTOR(1-4254) and yTA-mTOR(4201-7650) plasmids were digested by <italic>Sal</italic>I and <italic>BssH</italic>II and by <italic>Xba</italic>I and <italic>BssH</italic>II, respectively. Each mTOR fragment was ligated into the pDNR-CMV vector (Clontech). The SalI-XbaI mTOR fragment from the pDNR-CMV-mTOR(1-4254) plasmid was ligated into the pDNR-CMV-mTOR(4201-7650) plasmid to generate the full length pDNR-CMV-mTOR(1-7650) expression vector. The HA epitope-tagged full-length mTOR was generated following the BD Creator cloning protocol (Clontech) using the pLP-CMV-HA vector as the acceptor plasmid. The Myc-Rictor expression vector was generated by assembling PCR fragments amplified from human Marathon-Ready brain cDNA (Clontech) to make the full-length <italic>Rictor</italic> expression vector. The ATG-containing 5â² primer and the stop codon-containing 3â² primer (described in <xref ref-type="table" rid="pone-0065586-t001">Table 1</xref>) introduced <italic>Sal</italic>I and <italic>Kpn</italic>I restriction sites, respectively. The final assembled fragment of <italic>Rictor</italic> (nucleotides 1-5191) was digested by the two endonucleases and ligated into the pCMV-Myc (Clontech) plasmid to generate the full length pCMV-Myc-Rictor (1-5191) expression vector. The HA-mTOR and Myc-Rictor truncation mutants were constructed by using the appropriate primers and PCR to generate different truncation mutants <xref rid="pone.0065586-ToralBarza1" ref-type="bibr">[31]</xref>, <xref rid="pone.0065586-Sarbassov2" ref-type="bibr">[32]</xref> (<xref ref-type="table" rid="pone-0065586-t001">Table 1</xref>). Since there are different SIN1 splice variants <xref rid="pone.0065586-Schroder1" ref-type="bibr">[33]</xref>, only the SIN1Î² full length expression vector was generated by using RT-PCR of mRNA from 293T cells followed by inserting into the CMV-HA vector. The oligonucleotides used to generate the full length SIN1Î² and its truncation mutants were also described in <xref ref-type="table" rid="pone-0065586-t001">Table 1</xref>.</p>
        <table-wrap id="pone-0065586-t001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>The oligonucleotide sequences used to generate various full length and truncation constructs of mTOR, Rictor, and SIN1Î².</title>
          </caption>
          <alternatives>
            <graphic id="pone-0065586-t001-1" xlink:href="pone.0065586.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DNA constructs</td>
                  <td align="left" rowspan="1" colspan="1">Sequence (5â²â3â²)</td>
                  <td align="left" rowspan="1" colspan="1">Restriction Enzyme site</td>
                  <td align="left" rowspan="1" colspan="1">Ampli-con (bp)</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<bold>mTOR constructs</bold>
</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-mTOR<sub>1-2549</sub> (full length)</td>
                  <td align="left" rowspan="1" colspan="1">F:CAATTGGTCGACATGCTTGGAACCGGACCTGC</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Mfe</italic>I, <italic>Sal</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">7674</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R:CAATTGGCGCGCTTACCAGAAAGGGCACCAGC</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Mfe</italic>I, <italic>BssH</italic>II</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-mTOR<sub>1-651</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">CAATTGGTCGACATGCTTGGAACCGGACCTGC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Mfe</italic>I, <italic>Sal</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">1977</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R:GCTAGCGCGCTACACTTGCACTGCGGTCTGGC</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Nhe</italic>I, <italic>BssH</italic>II</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-mTOR<sub>640-1418</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">CAATTGGTCGACCATGCTCATGTGGTTAGCC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Mfe</italic>I, <italic>Sal</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">2361</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R:GCTAGCGCGCTAGCTGATGAGAGATTCTAGAATGG</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Nhe</italic>I, <italic>BssH</italic>II</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-mTOR<sub>1401-2549</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">GAACTGGAGTTCCAGAAAGGC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Xba</italic>I from vector</td>
                  <td align="left" rowspan="1" colspan="1">3466</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R: <named-content content-type="gene">CAATTGGCGCGCTTACCAGAAAGGGCACCAGC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Mfe</italic>I, <italic>BssH</italic>II</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<bold>Rictor constructs</bold>
</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-Myc-Rictor<sub>1-1708</sub> (full length)</td>
                  <td align="left" rowspan="1" colspan="1">F:GATTGACGTCGACCGTCAATATGGCGGCGATCG</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Sal</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">5170</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R:CTGGTACCATCATAAATATGAGGTCAGGATTC</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Kpn</italic>I</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-Myc-Rictor<sub>1-789</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F:GATTGACGTCGACCGTCAATATGGCGGCGATCG</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Sal</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">2407</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R:CTGGTACCTACTGAATGAGAGCATGAAGATTGGC</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Kpn</italic>I</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-Myc-Rictor<sub>664-1708</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">TGCGTCGACTGGAACACTTTCTTGCCACCCTC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Sal</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">3171</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R: <named-content content-type="gene">CTGGTACCATCATAAATATGAGGTCAGGATTC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Kpn</italic>I</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<bold>SIN1Î² constructs</bold>
</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-SIN1Î²</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">CGGAATTCCGGCCTTCTTGGACA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>EcoR</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">1461</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(full length)</td>
                  <td align="left" rowspan="1" colspan="1">R: <named-content content-type="gene">GAAGATCTTCACTGCTGCCCGG</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Bgl</italic>II</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-SIN1Î²<sub>1-267</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">CCGGAATTCGGATGGCCTTCTTGGAC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>EcoR</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">801</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R: <named-content content-type="gene">CGGGGTACCTCACTTTTCAACCAGGGC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Kpn</italic>I</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-SIN1Î²<sub>266-486</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">CCGGAATTCGGGAAAAGTACTCATCT</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>EcoR</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">666</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R: <named-content content-type="gene">CGGGGTACCTCACTGCTGCCCGGA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Kpn</italic>I</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">pCMV-HA-SIN1Î²<sub>334-486</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">F: <named-content content-type="gene">CCGGAATTCGGGACATAGCCACAGTA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>EcoR</italic>I</td>
                  <td align="left" rowspan="1" colspan="1">462</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">R: <named-content content-type="gene">CGGGGTACCTCACTGCTGCCCGGA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Kpn</italic>I</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
          </alternatives>
        </table-wrap>
      </sec>
      <sec id="s4b">
        <title>Western Blot Analysis and Co-immunoprecipitation Assays</title>
        <p>Western blot analysis was performed as described <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>. For Western blot analysis, 50 Âµg protein extracts from each clone were loaded to 10% SDS-PAGE gels and transferred to nitrocellulose filters. The filters were probed with various antibodies (described in <xref ref-type="table" rid="pone-0065586-t002">Table 2</xref>) and an anti-Ã-actin antibody was selected as a loading control. Signals were developed using an ECL chemiluminescence kit (Amersham Biosciences, U.K.).</p>
        <table-wrap id="pone-0065586-t002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0065586.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>List of proteins and characteristics of the corresponding antibodies used to detect the proteins.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0065586-t002-2" xlink:href="pone.0065586.t002"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Protein</td>
                  <td align="left" rowspan="1" colspan="1">Assay</td>
                  <td align="left" rowspan="1" colspan="1">Antibody</td>
                  <td align="left" rowspan="1" colspan="1">Origin</td>
                  <td align="left" rowspan="1" colspan="1">Dilution</td>
                  <td align="left" rowspan="1" colspan="1">Incubation period</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NBS1</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#3002, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NBS1</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">NB100-143, Novus Biologicals</td>
                  <td align="left" rowspan="1" colspan="1">1â¶10000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NBS1</td>
                  <td align="left" rowspan="1" colspan="1">IP</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">NB100-143, Novus Biologicals</td>
                  <td align="left" rowspan="1" colspan="1">1.0 Âµl</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">mTOR</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#2972, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">mTOR</td>
                  <td align="left" rowspan="1" colspan="1">IP</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#2972, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">5.0 Âµl</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Rictor</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">mmab</td>
                  <td align="left" rowspan="1" colspan="1">H00253260-M01, Abnova</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Rictor</td>
                  <td align="left" rowspan="1" colspan="1">IP</td>
                  <td align="left" rowspan="1" colspan="1">mmab</td>
                  <td align="left" rowspan="1" colspan="1">H00253260-M01, Abnova</td>
                  <td align="left" rowspan="1" colspan="1">5.0 Âµl</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SIN1</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">A300-910A, Bethyl Laboratories</td>
                  <td align="left" rowspan="1" colspan="1">1â¶2000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Flag</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">mmab</td>
                  <td align="left" rowspan="1" colspan="1">F3165, Sigma-Aldrich</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">1 hour</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Flag</td>
                  <td align="left" rowspan="1" colspan="1">IP</td>
                  <td align="left" rowspan="1" colspan="1">mmab</td>
                  <td align="left" rowspan="1" colspan="1">F3165, Sigma-Aldrich</td>
                  <td align="left" rowspan="1" colspan="1">5.0 Âµl</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">His-tag</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">mmab</td>
                  <td align="left" rowspan="1" colspan="1">H1029, Sigma-Aldrich</td>
                  <td align="left" rowspan="1" colspan="1">1â¶10000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Myc-tag</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">mmab</td>
                  <td align="left" rowspan="1" colspan="1">LTK Biolaboratories</td>
                  <td align="left" rowspan="1" colspan="1">1â¶500</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Akt</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#9272, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">p-Akt</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#9271, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">p-GSK-3Î²</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#9336, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">p-Foxo1/3a</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#9464, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">GSK-3Î²</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rmab</td>
                  <td align="left" rowspan="1" colspan="1">#9315, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Foxo1</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">rpab</td>
                  <td align="left" rowspan="1" colspan="1">#9454, Cell Signaling Technology</td>
                  <td align="left" rowspan="1" colspan="1">1â¶1000</td>
                  <td align="left" rowspan="1" colspan="1">Overnight</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Actin</td>
                  <td align="left" rowspan="1" colspan="1">WB</td>
                  <td align="left" rowspan="1" colspan="1">mmab</td>
                  <td align="left" rowspan="1" colspan="1">A5441, Sigma-Aldrich</td>
                  <td align="left" rowspan="1" colspan="1">1â¶20000</td>
                  <td align="left" rowspan="1" colspan="1">1 hour</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <p>Abbreviations: WB, Western blot; IP, Immunoprecipitation; mmab, mouse monoclonal antibody; rpab, rabbit polyclonal antibody.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Co-immunoprecipitation assays were performed as described <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>, <xref rid="pone.0065586-Tsai1" ref-type="bibr">[34]</xref>. Briefly, the anti-NBS1, anti-mTOR, anti-Rictor, anti-SIN1, anti-HA, or anti-Myc antibody was incubated for 5 h with 500 Âµl of whole cell extracts prepared by lysis in 150 mM NaCl, 1% Nonidet P-40, 1% deoxycholate, 0.1% SDS, 50 mM Tris.HCl-pH 7.5, and protease inhibitors, from 293T cells overexpressing proteins of interest or from H1299 cells to detect <italic>in</italic>
<italic>vivo</italic> interaction. The immune complexes were incubated overnight with protein-A beads, preblocked with 10% BSA. The immunoprecipitates were washed 3 times with TNTG buffer (20 mM Tris.HCl-pH 7.5, 150 mM NaCl, 0.1% Triton-X 100, 10% glycerol), mixed with 1x Laemmli dye, boiled for 10 min and loaded on SDS- polyacrylamide (SDS-PAGE) gels <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>. After transfer, the filters were blocked with blocking buffer <xref rid="pone.0065586-Chen2" ref-type="bibr">[12]</xref>, probed with primary and secondary antibody sequentially and developed. The antibodies used are described in <xref ref-type="table" rid="pone-0065586-t002">Table 2</xref>. Data shown are representative of at least 2 experiments from independent cell cultures or different transfections.</p>
      </sec>
      <sec id="s4c">
        <title>Sucrose Density Gradient Analysis</title>
        <p>A sucrose density gradient was generated as described <xref rid="pone.0065586-Damaraju1" ref-type="bibr">[35]</xref> and the extracts of H1299 cells were loaded to the continuous gradient. After centrifugation, the proteins were collected from different fractions, run on SDS-PAGE, and transferred to membranes. The blot was probed with various antibodies to detect the presence of different components of mTOR/Rictor/SIN1 and NBS1.</p>
      </sec>
      <sec id="s4d">
        <title>Ionizing Radiation (IR)</title>
        <p>Exponentially growing cells were temporarily incubated with 2 ml of PBS in 10 cm dishes and were irradiated at room temperature using <sup>60</sup>Co Î³-ray source with a dose of 5.0 Gy (dose rate 3 Gy/min). After irradiation, cells were washed twice with PBS and cultured in fresh DMEM medium containing 10% FBS for another 12 hours followed by harvesting for Western blot analysis.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Nile Wu and Cindy Lee for technical assistance.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0065586-Czorna1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<name><surname>Czorna</surname><given-names>K</given-names></name>, <name><surname>Chunghtai</surname><given-names>S</given-names></name>, <name><surname>Chrzanowska</surname><given-names>KH</given-names></name> (<year>2008</year>) <article-title>Mystery of DNA repair: the role of MRN complex and ATM kinase in DNA damage repair</article-title>. <source>J Appl Genet</source>
<volume>49</volume>: <fpage>383</fpage>â<lpage>396</lpage>.<pub-id pub-id-type="pmid">19029686</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Antoccia1">
        <label>2</label>
        <mixed-citation publication-type="journal">
<name><surname>Antoccia</surname><given-names>A</given-names></name>, <name><surname>Kobayashi</surname><given-names>J</given-names></name>, <name><surname>Tauchi</surname><given-names>H</given-names></name>, <name><surname>Matsuura</surname><given-names>S</given-names></name>, <name><surname>Komatsu</surname><given-names>K</given-names></name> (<year>2006</year>) <article-title>Nijmegen breakage syndrome and functions of the responsible protein, NBS1</article-title>. <source>Genome Dyn</source>
<volume>1</volume>: <fpage>191</fpage>â<lpage>205</lpage>.<pub-id pub-id-type="pmid">18724061</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-DAmours1">
        <label>3</label>
        <mixed-citation publication-type="journal">
<name><surname>DâAmours</surname><given-names>D</given-names></name>, <name><surname>Jackson</surname><given-names>SP</given-names></name> (<year>2002</year>) <article-title>The Mre11 complex: at the crossroads of DNA repair and checkpoint signaling</article-title>. <source>Nature Rev Mol Cell Biol</source>
<volume>3</volume>: <fpage>317</fpage>â<lpage>327</lpage>.<pub-id pub-id-type="pmid">11988766</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-LimD1">
        <label>4</label>
        <mixed-citation publication-type="journal">
<name><surname>Lim D</surname><given-names>S</given-names></name>, <name><surname>Kim</surname><given-names>ST</given-names></name>, <name><surname>Xu</surname><given-names>B</given-names></name>, <name><surname>Maser</surname><given-names>RS</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway</article-title>. <source>Nature</source>
<volume>404</volume>: <fpage>613</fpage>â<lpage>617</lpage>.<pub-id pub-id-type="pmid">10766245</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Zhao1">
        <label>5</label>
        <mixed-citation publication-type="journal">
<name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Weng</surname><given-names>YC</given-names></name>, <name><surname>Yuan</surname><given-names>SS</given-names></name>, <name><surname>Lin</surname><given-names>YT</given-names></name>, <name><surname>Hsu</surname><given-names>HC</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products</article-title>. <source>Nature</source>
<volume>405</volume>: <fpage>474</fpage>â<lpage>477</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0065586-Wu1">
        <label>6</label>
        <mixed-citation publication-type="journal">
<name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Ranganathan</surname><given-names>V</given-names></name>, <name><surname>Weisman</surname><given-names>DS</given-names></name>, <name><surname>Heine</surname><given-names>WF</given-names></name>, <name><surname>Ciccone</surname><given-names>DN</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response</article-title>. <source>Nature</source>
<volume>405</volume>: <fpage>477</fpage>â<lpage>482</lpage>.<pub-id pub-id-type="pmid">10839545</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Chiang1">
        <label>7</label>
        <mixed-citation publication-type="journal">
<name><surname>Chiang</surname><given-names>YC</given-names></name>, <name><surname>Teng</surname><given-names>SC</given-names></name>, <name><surname>Su</surname><given-names>YN</given-names></name>, <name><surname>Hsieh</surname><given-names>FJ</given-names></name>, <name><surname>Wu</surname><given-names>KJ</given-names></name> (<year>2003</year>) <article-title>c-MYC directly regulates the transcription of <italic>NBS1</italic> gene involved in DNA double-strand break repair</article-title>. <source>J Biol Chem</source>
<volume>278</volume>: <fpage>19286</fpage>â<lpage>19291</lpage>.<pub-id pub-id-type="pmid">12637527</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Zhu1">
        <label>8</label>
        <mixed-citation publication-type="journal">
<name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Petersen</surname><given-names>S</given-names></name>, <name><surname>Tessarollo</surname><given-names>L</given-names></name>, <name><surname>Nussenzweig</surname><given-names>A</given-names></name> (<year>2001</year>) <article-title>Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice</article-title>. <source>Curr Biol</source>
<volume>11</volume>: <fpage>105</fpage>â<lpage>109</lpage>.<pub-id pub-id-type="pmid">11231126</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Williams1">
        <label>9</label>
        <mixed-citation publication-type="journal">
<name><surname>Williams</surname><given-names>BR</given-names></name>, <name><surname>Mirzoeva</surname><given-names>OK</given-names></name>, <name><surname>Morgan</surname><given-names>WF</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <name><surname>Dunnick</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Murine model of Nijmegen breakage syndrome</article-title>. <source>Curr Biol</source>
<volume>12</volume>: <fpage>648</fpage>â<lpage>53</lpage>.<pub-id pub-id-type="pmid">11967151</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Kang1">
        <label>10</label>
        <mixed-citation publication-type="journal">
<name><surname>Kang</surname><given-names>J</given-names></name>, <name><surname>Bronson</surname><given-names>RT</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name> (<year>2002</year>) <article-title>Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair</article-title>. <source>EMBO J</source>
<volume>21</volume>: <fpage>1447</fpage>â<lpage>55</lpage>.<pub-id pub-id-type="pmid">11889050</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Chen1">
        <label>11</label>
        <mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>YC</given-names></name>, <name><surname>Su</surname><given-names>YN</given-names></name>, <name><surname>Chou</surname><given-names>PC</given-names></name>, <name><surname>Chiang</surname><given-names>WC</given-names></name>, <name><surname>Chang</surname><given-names>MC</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt</article-title>. <source>J Biol Chem</source>
<volume>280</volume>: <fpage>32505</fpage>â<lpage>32511</lpage>.<pub-id pub-id-type="pmid">16036916</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Chen2">
        <label>12</label>
        <mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>YC</given-names></name>, <name><surname>Chiang</surname><given-names>HY</given-names></name>, <name><surname>Yang</surname><given-names>MH</given-names></name>, <name><surname>Chen</surname><given-names>PM</given-names></name>, <name><surname>Chang</surname><given-names>SY</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Activation of phosphoinositide 3-kinase by the NBS1 DNA repair protein</article-title>. <source>J Mol Med</source>
<volume>86</volume>: <fpage>401</fpage>â<lpage>412</lpage>.<pub-id pub-id-type="pmid">18270679</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Yang1">
        <label>13</label>
        <mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>MH</given-names></name>, <name><surname>Chiang</surname><given-names>WC</given-names></name>, <name><surname>Chang</surname><given-names>SY</given-names></name>, <name><surname>Chen</surname><given-names>PM</given-names></name>, <name><surname>Teng</surname><given-names>SC</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Increased NBS1 expression is a marker of aggressive head and neck cancer and overepxression of NBS1 promotes transformation</article-title>. <source>Clin Cancer Res</source>
<volume>12</volume>: <fpage>507</fpage>â<lpage>515</lpage>.<pub-id pub-id-type="pmid">16428493</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Cantley1">
        <label>14</label>
        <mixed-citation publication-type="journal">
<name><surname>Cantley</surname><given-names>LC</given-names></name> (<year>2002</year>) <article-title>The phosphoinositide 3-kinase pathway</article-title>. <source>Science</source>
<volume>296</volume>: <fpage>1655</fpage>â<lpage>1657</lpage>.<pub-id pub-id-type="pmid">12040186</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Vivanco1">
        <label>15</label>
        <mixed-citation publication-type="journal">
<name><surname>Vivanco</surname><given-names>I</given-names></name>, <name><surname>Sawyers</surname><given-names>CL</given-names></name> (<year>2002</year>) <article-title>The phosphatidylinositol 3-kinase-Akt pathway in human cancer</article-title>. <source>Nature Rev Cancer</source>
<volume>2</volume>: <fpage>489</fpage>â<lpage>501</lpage>.<pub-id pub-id-type="pmid">12094235</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Bellacosa1">
        <label>16</label>
        <mixed-citation publication-type="journal">
<name><surname>Bellacosa</surname><given-names>A</given-names></name>, <name><surname>Chan</surname><given-names>TO</given-names></name>, <name><surname>Ahmed</surname><given-names>NN</given-names></name>, <name><surname>Datta</surname><given-names>K</given-names></name>, <name><surname>Malstrom</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Akt activation by growth factors is a multiple-step process: the role of the PH domain</article-title>. <source>Oncogene</source>
<volume>17</volume>: <fpage>313</fpage>â<lpage>325</lpage>.<pub-id pub-id-type="pmid">9690513</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Sarbassov1">
        <label>17</label>
        <mixed-citation publication-type="journal">
<name><surname>Sarbassov</surname><given-names>DD</given-names></name>, <name><surname>Guertin</surname><given-names>DA</given-names></name>, <name><surname>Ali</surname><given-names>SM</given-names></name>, <name><surname>Sabatini</surname><given-names>DM</given-names></name> (<year>2005</year>) <article-title>Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex</article-title>. <source>Science</source>
<volume>307</volume>: <fpage>1098</fpage>â<lpage>1101</lpage>.<pub-id pub-id-type="pmid">15718470</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Testa1">
        <label>18</label>
        <mixed-citation publication-type="journal">
<name><surname>Testa</surname><given-names>JR</given-names></name>, <name><surname>Bellacosa</surname><given-names>A</given-names></name> (<year>2001</year>) <article-title>AKT plays a central role in tumorigenesis</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>98</volume>: <fpage>10983</fpage>â<lpage>10985</lpage>.<pub-id pub-id-type="pmid">11572954</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Jacinto1">
        <label>19</label>
        <mixed-citation publication-type="journal">
<name><surname>Jacinto</surname><given-names>E</given-names></name>, <name><surname>Facchinetti</surname><given-names>V</given-names></name>, <name><surname>Liu</surname><given-names>D</given-names></name>, <name><surname>Soto</surname><given-names>N</given-names></name>, <name><surname>Wei</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity</article-title>. <source>Cell</source>
<volume>126</volume>: <fpage>1</fpage>â<lpage>13</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0065586-Yang2">
        <label>20</label>
        <mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Inoki</surname><given-names>K</given-names></name>, <name><surname>Ikenoue</surname><given-names>T</given-names></name>, <name><surname>Guan</surname><given-names>KL</given-names></name> (<year>2006</year>) <article-title>Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity</article-title>. <source>Genes &amp; Dev</source>
<volume>20</volume>: <fpage>2820</fpage>â<lpage>2832</lpage>.<pub-id pub-id-type="pmid">17043309</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Frias1">
        <label>21</label>
        <mixed-citation publication-type="journal">
<name><surname>Frias</surname><given-names>MA</given-names></name>, <name><surname>Thoreen</surname><given-names>CC</given-names></name>, <name><surname>Jaffe</surname><given-names>JD</given-names></name>, <name><surname>Schroder</surname><given-names>W</given-names></name>, <name><surname>Sculley</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s</article-title>. <source>Curr Biol</source>
<volume>16</volume>: <fpage>1865</fpage>â<lpage>1870</lpage>.<pub-id pub-id-type="pmid">16919458</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Huang1">
        <label>22</label>
        <mixed-citation publication-type="journal">
<name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Dibble</surname><given-names>CC</given-names></name>, <name><surname>Matuszaki</surname><given-names>M</given-names></name>, <name><surname>Manning</surname><given-names>BD</given-names></name> (<year>2008</year>) <article-title>The TSC1-TSC2 complex is required for proper activation of mTOR complex 2</article-title>. <source>Mol Cell Biol</source>
<volume>28</volume>: <fpage>4104</fpage>â<lpage>4115</lpage>.<pub-id pub-id-type="pmid">18411301</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Contessa1">
        <label>23</label>
        <mixed-citation publication-type="journal">
<name><surname>Contessa</surname><given-names>JN</given-names></name>, <name><surname>Hampton</surname><given-names>J</given-names></name>, <name><surname>Lammering</surname><given-names>G</given-names></name>, <name><surname>Mikkelsen</surname><given-names>RB</given-names></name>, <name><surname>Dent</surname><given-names>P</given-names></name>, <name><surname>Valerie</surname><given-names>K</given-names></name>, <name><surname>Schmidt-Ullrich</surname><given-names>RK</given-names></name> (<year>2002</year>) <article-title>Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells</article-title>. <source>Oncogene</source>
<volume>21</volume>: <fpage>4032</fpage>â<lpage>4041</lpage>.<pub-id pub-id-type="pmid">12037685</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Suman1">
        <label>24</label>
        <mixed-citation publication-type="journal">
<name><surname>Suman</surname><given-names>S</given-names></name>, <name><surname>Johnson</surname><given-names>MD</given-names></name>, <name><surname>Fornace</surname><given-names>AJ</given-names><suffix>Jr</suffix></name>, <name><surname>Datta</surname><given-names>K</given-names></name> (<year>2012</year>) <article-title>Exposure to ionizing radiation causes long-term increase in serum restradiol and activation of PI3K-Akt signaling in mouse mammary gland</article-title>. <source>Int J Radiat Oncol Biol Phys</source>
<volume>84</volume>: <fpage>500</fpage>â<lpage>507</lpage>.<pub-id pub-id-type="pmid">22381906</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Saidi1">
        <label>25</label>
        <mixed-citation publication-type="journal">
<name><surname>Saidi</surname><given-names>A</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Weih</surname><given-names>F</given-names></name>, <name><surname>Concannon</surname><given-names>P</given-names></name>, <name><surname>Wang</surname><given-names>ZQ</given-names></name> (<year>2010</year>) <article-title>Dual function of Nbs1 in the repair of DNA breaks and proliferation ensure proper V(D)J recombination and T-cell development</article-title>. <source>Mol Cell Biol</source>
<volume>30</volume>: <fpage>5572</fpage>â<lpage>5581</lpage>.<pub-id pub-id-type="pmid">20921278</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Hematulin1">
        <label>26</label>
        <mixed-citation publication-type="journal">
<name><surname>Hematulin</surname><given-names>A</given-names></name>, <name><surname>Sagan</surname><given-names>D</given-names></name>, <name><surname>Eckardt-Schupp</surname><given-names>F</given-names></name>, <name><surname>Moertl</surname><given-names>S</given-names></name> (<year>2008</year>) <article-title>NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade</article-title>. <source>Cell Signal</source>
<volume>20</volume>
<fpage>2276</fpage>â<lpage>2285</lpage>.<pub-id pub-id-type="pmid">18793719</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Culjkovic1">
        <label>27</label>
        <mixed-citation publication-type="journal">
<name><surname>Culjkovic</surname><given-names>B</given-names></name>, <name><surname>Tan</surname><given-names>K</given-names></name>, <name><surname>Orolicki</surname><given-names>S</given-names></name>, <name><surname>Amri</surname><given-names>A</given-names></name>, <name><surname>Meloche</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The eIF4E RNA regulon promotes the Akt signaling pathway</article-title>. <source>J Cell Biol</source>
<volume>181</volume>: <fpage>51</fpage>â<lpage>63</lpage>.<pub-id pub-id-type="pmid">18391071</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Woo1">
        <label>28</label>
        <mixed-citation publication-type="journal">
<name><surname>Woo</surname><given-names>SY</given-names></name>, <name><surname>Kim</surname><given-names>DH</given-names></name>, <name><surname>Jun</surname><given-names>CB</given-names></name>, <name><surname>Kim</surname><given-names>YM</given-names></name>, <name><surname>Vander-Haar</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>PRR5, a novel component of mTOR complex 2, regulates PDGFÎ² expression and signaling</article-title>. <source>J Biol Chem</source>
<volume>282</volume>: <fpage>25604</fpage>â<lpage>25612</lpage>.<pub-id pub-id-type="pmid">17599906</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Yang3">
        <label>29</label>
        <mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>MH</given-names></name>, <name><surname>Chang</surname><given-names>SY</given-names></name>, <name><surname>Chiou</surname><given-names>SH</given-names></name>, <name><surname>Liu</surname><given-names>CJ</given-names></name>, <name><surname>Chi</surname><given-names>CW</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer</article-title>. <source>Oncogene</source>
<volume>26</volume>: <fpage>1459</fpage>â<lpage>1467</lpage>.<pub-id pub-id-type="pmid">16936774</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Yang4">
        <label>30</label>
        <mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>MH</given-names></name>, <name><surname>Wu</surname><given-names>MZ</given-names></name>, <name><surname>Chiou</surname><given-names>SH</given-names></name>, <name><surname>Chen</surname><given-names>PM</given-names></name>, <name><surname>Chang</surname><given-names>SY</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Direct regulation of TWIST by HIF-1Î± promotes metastasis</article-title>. <source>Nature Cell Biol</source>
<volume>10</volume>: <fpage>295</fpage>â<lpage>305</lpage>.<pub-id pub-id-type="pmid">18297062</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-ToralBarza1">
        <label>31</label>
        <mixed-citation publication-type="journal">
<name><surname>Toral-Barza</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>WG</given-names></name>, <name><surname>Lamison</surname><given-names>C</given-names></name>, <name><surname>LaRocque</surname><given-names>J</given-names></name>, <name><surname>Gibbons</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Characterization of the cloned full-length and a truncated human target of rapamycin: activity, specificity, and enzyme inhibition as studied by a high capacity assay</article-title>. <source>Biochem Biophy Res Comm</source>
<volume>332</volume>: <fpage>304</fpage>â<lpage>310</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0065586-Sarbassov2">
        <label>32</label>
        <mixed-citation publication-type="journal">
<name><surname>Sarbassov</surname><given-names>DD</given-names></name>, <name><surname>Ali</surname><given-names>SM</given-names></name>, <name><surname>Kim</surname><given-names>DH</given-names></name>, <name><surname>Guertin</surname><given-names>DA</given-names></name>, <name><surname>Latek</surname><given-names>RR</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and Raptor-independent pathway that regulates the cytoskeleton</article-title>. <source>Curr Biol</source>
<volume>14</volume>: <fpage>1296</fpage>â<lpage>1302</lpage>.<pub-id pub-id-type="pmid">15268862</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Schroder1">
        <label>33</label>
        <mixed-citation publication-type="journal">
<name><surname>Schroder</surname><given-names>W</given-names></name>, <name><surname>Cloonan</surname><given-names>N</given-names></name>, <name><surname>Bushell</surname><given-names>G</given-names></name>, <name><surname>Sculley</surname><given-names>T</given-names></name> (<year>2004</year>) <article-title>Alternative polyadenylation and splicing of mRNAs transcribed from the human Sin1 gene</article-title>. <source>Gene</source>
<volume>339</volume>: <fpage>17</fpage>â<lpage>23</lpage>.<pub-id pub-id-type="pmid">15363842</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Tsai1">
        <label>34</label>
        <mixed-citation publication-type="journal">
<name><surname>Tsai</surname><given-names>YP</given-names></name>, <name><surname>Yang</surname><given-names>MH</given-names></name>, <name><surname>Huang</surname><given-names>CH</given-names></name>, <name><surname>Chang</surname><given-names>SY</given-names></name>, <name><surname>Chen</surname><given-names>PM</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Interaction between HSP60 and Î²-catenin promotes metastasis</article-title>. <source>Carcinogenesis</source>
<volume>30</volume>: <fpage>1049</fpage>â<lpage>1057</lpage>.<pub-id pub-id-type="pmid">19369584</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0065586-Damaraju1">
        <label>35</label>
        <mixed-citation publication-type="journal">
<name><surname>Damaraju</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>N</given-names></name>, <name><surname>Li</surname><given-names>N</given-names></name>, <name><surname>Tao</surname><given-names>L</given-names></name>, <name><surname>Damaraju</surname><given-names>VL</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Evidence for copurification of micronuclei in sucrose density gradient-enriched plasma membranes from cell lines</article-title>. <source>Anal Biochem</source>
<volume>396</volume>: <fpage>69</fpage>â<lpage>75</lpage>.<pub-id pub-id-type="pmid">19699175</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>